In addition to HIV, Russia is beset by an epidemic of
tuberculosis that is set to break world records. The country's
post-Soviet economic decline and tattered social safety net
conspired to breathe new life into the once-tamed virus.
Since 1991, the number of Russians with TB has nearly
tripled. The country is averaging 150,000 new cases
annually. Last year, deaths due to TB - a contagious,
airborne disease - rose 30%.
The source of infection, in the vast majority of cases, is a jail
cell. Russia's teeming prisons rank among the world's most
prodigious TB incubators. Among the country's 1 million
inmates, as many as 100,000 carry the virus. Worse still,
Russia is one of the leading hot zones in producing TB
strains that do not respond to traditional drug treatments -
so-called multidrug resistant, or MDR, strains.
"Multidrug resistant TB is man-made, resulting from the failed
treatment of a regular TB case," says Yekaterina
Goncharova, Moscow medical coordinator for New York's
Public Health Research Institute (phri), which in 1997
launched a war on TB in Russia with $14 million from U.S.
financier George Soros. In a 1999 report, Dr.
Paul Farmer, an infectious disease specialist at Harvard
University and a leading authority on tuberculosis around the
world, reported that more than half of all TB carriers in
Russian prisons are resistant to at least one anti-TB drug.
MDR cases can be treated with a 75% success rate in a new
therapy developed by Farmer in Peru and endorsed by the
World Health Organization in 1998. But treatment is
expensive and lengthy. Drugs for a traditional case of TB cost
$20 in Russia, but treating an MDR case can require up to
$15,000 and two years. This winter, phri and the British
medical relief group merlin launched a pilot program for
treating drug-resistant TB in Russia, thanks to a $4 million
program funded by Soros and the European Union. Fifty
inmates in a prison hospital in Tomsk are now receiving the
best drug cocktails available. "It's a small beginning," admits
Goncharova, "but we hope to build a model that can be
replicated in other cities."
For that to happen, there must be funds. Soros is not
expected to continue his largesse in 2001. The World Bank
has pledged $100 million for TB programs in Russia, but that
money is not expected until year's end at the earliest. At the
same time, few among those who control Russia's finances
realize the danger TB poses. "So far, those who are dying
have died out of sight behind the prison walls," says
Goncharova.
Soon that will change. Because of the scarcity of state funds,
tens of thousands of prisoners are released early every year.
In 1999, more than 1,000 prisoners with active TB were
amnestied in the Voronezh region, site of one of Russia's
largest TB prison colonies. Last summer, Voronezh
experienced a TB infection rate 150% higher than the
previous year's.
Experts fear Russia's epidemic because the disease knows
no borders. "No country in Western Europe is experiencing as
high an increase in TB," says Dr. Mario Raviglione, TB
coordinator for the who in Geneva. "What Russia breeds will
infect not only Russians but Europeans, Americans, even
Israelis." The Tomsk project is a hopeful beginning. Yet both
Russian experts and their partners from abroad agree that
the battle to control TB will take years, if not decades. For
many patients it is already too late, they say. And for millions
more, it is only a matter of time and money - commodities in
short supply in Russia's health care system.